
Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney
Author(s) -
Bernd Hohenstein,
MeiChuan Kuo,
Francesco Addabbo,
Kaoru Yasuda,
Brian B. Ratliff,
Claudia Schwarzenberger,
KaiUwe Eckardt,
Christian Hugo,
Michael S. Goligorsky
Publication year - 2010
Publication title -
american journal of physiology. renal physiology./american journal of physiology. renal physiology
Language(s) - English
Resource type - Journals
eISSN - 1931-857X
pISSN - 1522-1466
DOI - 10.1152/ajprenal.00025.2010
Subject(s) - homing (biology) , progenitor cell , endothelial stem cell , endothelial progenitor cell , stem cell , erythropoietin , microbiology and biotechnology , immunology , kidney , biology , angiogenesis , endothelium , haematopoiesis , cancer research , medicine , endocrinology , ecology , biochemistry , in vitro
Primary and/or secondary injury of the renal microvascular endothelium is a common finding in various renal diseases. Besides well-known endothelial repair mechanisms, including endothelial cell (EC) proliferation and migration, homing of extrinsic cells such as endothelial progenitor cells (EPC) and hematopoietic stem cells (HSC) has been shown in various organs and may contribute to microvascular repair. However, these mechanisms have so far not been studied after selective microvascular injury in the kidney. The present study investigated the time course of EPC and HSC stimulation and homing following induction of selective EC injury in the mouse kidney along with various angiogenic factors potentially involved in EC repair and progenitor cell stimulation. Erythropoietin was used to stimulate progenitor cells in a therapeutic approach. We found that selective EC injury leads to a marked stimulation of EPCs, HSCs, and various angiogenic factors to orchestrate microvascular repair. Angiogenic factors started to increase as early as 30 min after disease induction. Progenitor cells could be first detected in the circulation and the spleen before they selectively homed to the diseased kidney. Injection of a high dose of erythropoietin 2 h after disease induction markedly attenuated vascular injury through nonhemodynamic mechanisms, possibly involving vascular endothelial growth factor release.